APA (7th ed.) Citation

HJ, H., X, L., HL, L., HY, W., JF, G., LY, S., . . . XY, L. (2021). Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model. Cancer immunology, immunotherapy : CII, 70(12), 3541. https://doi.org/10.1007/s00262-021-02946-z

Chicago Style (17th ed.) Citation

HJ, Hu, et al. "Enhanced Anti-melanoma Efficacy Through a Combination of the Armed Oncolytic Adenovirus ZD55-IL-24 and Immune Checkpoint Blockade in B16-bearing Immunocompetent Mouse Model." Cancer Immunology, Immunotherapy : CII 70, no. 12 (2021): 3541. https://doi.org/10.1007/s00262-021-02946-z.

MLA (9th ed.) Citation

HJ, Hu, et al. "Enhanced Anti-melanoma Efficacy Through a Combination of the Armed Oncolytic Adenovirus ZD55-IL-24 and Immune Checkpoint Blockade in B16-bearing Immunocompetent Mouse Model." Cancer Immunology, Immunotherapy : CII, vol. 70, no. 12, 2021, p. 3541, https://doi.org/10.1007/s00262-021-02946-z.